Press release
Scientists at the University of Dundee and Harvard Medical School have identified the key targets of an enzyme that play a critical role in protecting the brain against the development of Parkinson’s disease.
Press release
Scientists at the University of Dundee and Harvard Medical School have identified the key targets of an enzyme that play a critical role in protecting the brain against the development of Parkinson’s disease.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Collaborative research between the Universities of Dundee and Cambridge has uncovered how ‘assassin’ immune cells are able keep on killing as they hunt down cancer cells, repeatedly reloading their toxic weapons.
Press release
Professor Sir Philip Cohen, one of the major influences in establishing Dundee as an international centre of excellence in life sciences research, has marked his 50th anniversary of joining the University of Dundee.
News
Vivien Shek, a second year PhD student, has been awarded a Royal Society of Edinburgh Saltire Early Career Fellowship.
News
Kirby Swatek will open an independent research laboratory in the MRC PPU at the beginning of 2022.
News
Virginia De Cesare has been awarded a UKRI Future Leaders Fellowship, one of the UK’s flagship fellowship schemes for early career investigators, in addition to being promoted to an Independent Investigator position within the MRC-PPU.
Press release
A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.
Press release
Treating mice that have a Parkinson’s disease-causing mutation with a small molecule compound restores the removal of damaged mitochondria from their brain cells, shows a study published today in eLife.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
Press release
Researchers at the University of Dundee have identified a new treatment target for coeliac disease that could relieve inflammation and unlock alternative treatment options
News
Seven new papers have been published this month in The Biochemical Journal, representing a major collaboration between multiple groups at the Francis Crick Institute in London, University College London and The University of Dundee.
Feature
Parkinson's is the fastest growing neurological condition in the world, for which there is no cure. Researchers at the University of Dundee are making significant advances in its understanding.
Press release
Some of Scotland’s most prominent Parkinson’s Disease campaigners and supporters are to cycle hundreds of miles for a University of Dundee fundraising campaign.
News
Gabriel Sollberger has been awarded funding from the Springboard scheme of the Academy of Medical Sciences, which is designed to help early career researchers establish their independent research programmes.
News
Collaborative research between scientists in the Division of Cell Signalling and Immunology and the University of Leeds has been published in eLife.
News
Last week, the University recognized students that go above and beyond in their annual Dundee Plus Awards.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.